山东省已上市生物制品备案变更的典型问题和风险分析
肖连立, 徐晓娟, 李德宝, 侯瑾, 张平, 刘福龙
Typical Problems and Risk Analysis of Post-Approval
Changes of Biological Products in Shandong Province
XIAO Lianli, XU Xiaojuan, LI Debao, HOU Jin, ZHANG Ping, LIU Fulong
中国医药导刊
.
2024, (8): 785
-789
.
